Global Dry Powder Inhalation Device Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Dry Powder Inhalation Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dry Powder Inhalation Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Dose
1.2.3 Multiple Doses
1.2.4 Storage Type
1.3 Market Segmentation by Application
1.3.1 Global Dry Powder Inhalation Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Asthmatic
1.3.3 COPD
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dry Powder Inhalation Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Dry Powder Inhalation Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dry Powder Inhalation Device Sales Estimates and Forecasts 2020-2031
2.4 Global Dry Powder Inhalation Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Dry Powder Inhalation Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Dry Powder Inhalation Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Dose Market Size by Manufacturers
3.5.2 Multiple Doses Market Size by Manufacturers
3.5.3 Storage Type Market Size by Manufacturers
3.6 Global Dry Powder Inhalation Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Dry Powder Inhalation Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Dry Powder Inhalation Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Dry Powder Inhalation Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Dry Powder Inhalation Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Dry Powder Inhalation Device Sales and Revenue by Type (2020-2031)
6.4 North America Dry Powder Inhalation Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Dry Powder Inhalation Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Dry Powder Inhalation Device Sales and Revenue by Type (2020-2031)
7.4 Europe Dry Powder Inhalation Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Dry Powder Inhalation Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Dry Powder Inhalation Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Dry Powder Inhalation Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Dry Powder Inhalation Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Dry Powder Inhalation Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Dry Powder Inhalation Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Dry Powder Inhalation Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Dry Powder Inhalation Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Dry Powder Inhalation Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Dry Powder Inhalation Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Catalent
11.1.1 Catalent Corporation Information
11.1.2 Catalent Business Overview
11.1.3 Catalent Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.1.4 Catalent Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Catalent Dry Powder Inhalation Device Sales by Product in 2024
11.1.6 Catalent Dry Powder Inhalation Device Sales by Application in 2024
11.1.7 Catalent Dry Powder Inhalation Device Sales by Geographic Area in 2024
11.1.8 Catalent Dry Powder Inhalation Device SWOT Analysis
11.1.9 Catalent Recent Developments
11.2 AptarGroup
11.2.1 AptarGroup Corporation Information
11.2.2 AptarGroup Business Overview
11.2.3 AptarGroup Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.2.4 AptarGroup Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 AptarGroup Dry Powder Inhalation Device Sales by Product in 2024
11.2.6 AptarGroup Dry Powder Inhalation Device Sales by Application in 2024
11.2.7 AptarGroup Dry Powder Inhalation Device Sales by Geographic Area in 2024
11.2.8 AptarGroup Dry Powder Inhalation Device SWOT Analysis
11.2.9 AptarGroup Recent Developments
11.3 H&T Presspart
11.3.1 H&T Presspart Corporation Information
11.3.2 H&T Presspart Business Overview
11.3.3 H&T Presspart Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.3.4 H&T Presspart Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 H&T Presspart Dry Powder Inhalation Device Sales by Product in 2024
11.3.6 H&T Presspart Dry Powder Inhalation Device Sales by Application in 2024
11.3.7 H&T Presspart Dry Powder Inhalation Device Sales by Geographic Area in 2024
11.3.8 H&T Presspart Dry Powder Inhalation Device SWOT Analysis
11.3.9 H&T Presspart Recent Developments
11.4 Vectura Delivery Devices
11.4.1 Vectura Delivery Devices Corporation Information
11.4.2 Vectura Delivery Devices Business Overview
11.4.3 Vectura Delivery Devices Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.4.4 Vectura Delivery Devices Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Vectura Delivery Devices Dry Powder Inhalation Device Sales by Product in 2024
11.4.6 Vectura Delivery Devices Dry Powder Inhalation Device Sales by Application in 2024
11.4.7 Vectura Delivery Devices Dry Powder Inhalation Device Sales by Geographic Area in 2024
11.4.8 Vectura Delivery Devices Dry Powder Inhalation Device SWOT Analysis
11.4.9 Vectura Delivery Devices Recent Developments
11.5 MannKind Corporation
11.5.1 MannKind Corporation Corporation Information
11.5.2 MannKind Corporation Business Overview
11.5.3 MannKind Corporation Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.5.4 MannKind Corporation Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 MannKind Corporation Dry Powder Inhalation Device Sales by Product in 2024
11.5.6 MannKind Corporation Dry Powder Inhalation Device Sales by Application in 2024
11.5.7 MannKind Corporation Dry Powder Inhalation Device Sales by Geographic Area in 2024
11.5.8 MannKind Corporation Dry Powder Inhalation Device SWOT Analysis
11.5.9 MannKind Corporation Recent Developments
11.6 MicroDose Therapeutx
11.6.1 MicroDose Therapeutx Corporation Information
11.6.2 MicroDose Therapeutx Business Overview
11.6.3 MicroDose Therapeutx Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.6.4 MicroDose Therapeutx Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 MicroDose Therapeutx Recent Developments
11.7 GSK
11.7.1 GSK Corporation Information
11.7.2 GSK Business Overview
11.7.3 GSK Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.7.4 GSK Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 GSK Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Business Overview
11.8.3 Novartis Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.8.4 Novartis Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Novartis Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.9.4 AstraZeneca Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 AstraZeneca Recent Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Corporation Information
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.10.4 Boehringer Ingelheim Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Boehringer Ingelheim Recent Developments
11.11 Orion Pharma
11.11.1 Orion Pharma Corporation Information
11.11.2 Orion Pharma Business Overview
11.11.3 Orion Pharma Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.11.4 Orion Pharma Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Orion Pharma Recent Developments
11.12 ​Liquidia Technologies​
11.12.1 ​Liquidia Technologies​ Corporation Information
11.12.2 ​Liquidia Technologies​ Business Overview
11.12.3 ​Liquidia Technologies​ Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.12.4 ​Liquidia Technologies​ Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 ​Liquidia Technologies​ Recent Developments
11.13 ​Teva Pharmaceutical Industries​
11.13.1 ​Teva Pharmaceutical Industries​ Corporation Information
11.13.2 ​Teva Pharmaceutical Industries​ Business Overview
11.13.3 ​Teva Pharmaceutical Industries​ Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.13.4 ​Teva Pharmaceutical Industries​ Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 ​Teva Pharmaceutical Industries​ Recent Developments
11.14 Chiesi​​
11.14.1 Chiesi​​ Corporation Information
11.14.2 Chiesi​​ Business Overview
11.14.3 Chiesi​​ Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.14.4 Chiesi​​ Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Chiesi​​ Recent Developments
11.15 Hovione
11.15.1 Hovione Corporation Information
11.15.2 Hovione Business Overview
11.15.3 Hovione Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.15.4 Hovione Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Hovione Recent Developments
11.16 Nemera
11.16.1 Nemera Corporation Information
11.16.2 Nemera Business Overview
11.16.3 Nemera Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.16.4 Nemera Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Nemera Recent Developments
11.17 Dürr
11.17.1 Dürr Corporation Information
11.17.2 Dürr Business Overview
11.17.3 Dürr Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.17.4 Dürr Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Dürr Recent Developments
11.18 Shanghai Huarui
11.18.1 Shanghai Huarui Corporation Information
11.18.2 Shanghai Huarui Business Overview
11.18.3 Shanghai Huarui Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.18.4 Shanghai Huarui Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Shanghai Huarui Recent Developments
11.19 Hangzhou Changxi Pharmaceutical
11.19.1 Hangzhou Changxi Pharmaceutical Corporation Information
11.19.2 Hangzhou Changxi Pharmaceutical Business Overview
11.19.3 Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.19.4 Hangzhou Changxi Pharmaceutical Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Hangzhou Changxi Pharmaceutical Recent Developments
11.20 Suzhou Inha Medicine
11.20.1 Suzhou Inha Medicine Corporation Information
11.20.2 Suzhou Inha Medicine Business Overview
11.20.3 Suzhou Inha Medicine Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.20.4 Suzhou Inha Medicine Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Suzhou Inha Medicine Recent Developments
11.21 Shenzhen Resproly Biopharmaceuticals
11.21.1 Shenzhen Resproly Biopharmaceuticals Corporation Information
11.21.2 Shenzhen Resproly Biopharmaceuticals Business Overview
11.21.3 Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Product Models, Descriptions and Specifications
11.21.4 Shenzhen Resproly Biopharmaceuticals Dry Powder Inhalation Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Shenzhen Resproly Biopharmaceuticals Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Dry Powder Inhalation Device Industry Chain
12.2 Dry Powder Inhalation Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Dry Powder Inhalation Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Dry Powder Inhalation Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Dry Powder Inhalation Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Dry Powder Inhalation Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Dry Powder Inhalation Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dry Powder Inhalation Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dry Powder Inhalation Device Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dry Powder Inhalation Device Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Dry Powder Inhalation Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Dry Powder Inhalation Device Sales by Region (2020-2025) & (K Units)
Table 8. Global Dry Powder Inhalation Device Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Dry Powder Inhalation Device Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Dry Powder Inhalation Device Sales Share by Manufacturers (2020-2025)
Table 12. Global Dry Powder Inhalation Device Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Dry Powder Inhalation Device Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Dry Powder Inhalation Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Device as of 2024)
Table 16. Global Dry Powder Inhalation Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Dry Powder Inhalation Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Dry Powder Inhalation Device Manufacturing Base and Headquarters
Table 19. Global Dry Powder Inhalation Device Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Dry Powder Inhalation Device Sales by Type (2020-2025) & (K Units)
Table 23. Global Dry Powder Inhalation Device Sales by Type (2026-2031) & (K Units)
Table 24. Global Dry Powder Inhalation Device Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Dry Powder Inhalation Device Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Dry Powder Inhalation Device ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Dry Powder Inhalation Device Sales by Application (2020-2025) & (K Units)
Table 29. Global Dry Powder Inhalation Device Sales by Application (2026-2031) & (K Units)
Table 30. Dry Powder Inhalation Device High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Dry Powder Inhalation Device Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Dry Powder Inhalation Device Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Dry Powder Inhalation Device ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Dry Powder Inhalation Device Growth Accelerators and Market Barriers
Table 37. North America Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Dry Powder Inhalation Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Dry Powder Inhalation Device Growth Accelerators and Market Barriers
Table 40. Europe Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Dry Powder Inhalation Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Dry Powder Inhalation Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Dry Powder Inhalation Device Growth Accelerators and Market Barriers
Table 45. Southeast Asia Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Dry Powder Inhalation Device Investment Opportunities and Key Challenges
Table 47. Central and South America Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Dry Powder Inhalation Device Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Dry Powder Inhalation Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Catalent Corporation Information
Table 51. Catalent Description and Major Businesses
Table 52. Catalent Product Models, Descriptions and Specifications
Table 53. Catalent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Catalent Sales Value Proportion by Product in 2024
Table 55. Catalent Sales Value Proportion by Application in 2024
Table 56. Catalent Sales Value Proportion by Geographic Area in 2024
Table 57. Catalent Dry Powder Inhalation Device SWOT Analysis
Table 58. Catalent Recent Developments
Table 59. AptarGroup Corporation Information
Table 60. AptarGroup Description and Major Businesses
Table 61. AptarGroup Product Models, Descriptions and Specifications
Table 62. AptarGroup Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. AptarGroup Sales Value Proportion by Product in 2024
Table 64. AptarGroup Sales Value Proportion by Application in 2024
Table 65. AptarGroup Sales Value Proportion by Geographic Area in 2024
Table 66. AptarGroup Dry Powder Inhalation Device SWOT Analysis
Table 67. AptarGroup Recent Developments
Table 68. H&T Presspart Corporation Information
Table 69. H&T Presspart Description and Major Businesses
Table 70. H&T Presspart Product Models, Descriptions and Specifications
Table 71. H&T Presspart Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. H&T Presspart Sales Value Proportion by Product in 2024
Table 73. H&T Presspart Sales Value Proportion by Application in 2024
Table 74. H&T Presspart Sales Value Proportion by Geographic Area in 2024
Table 75. H&T Presspart Dry Powder Inhalation Device SWOT Analysis
Table 76. H&T Presspart Recent Developments
Table 77. Vectura Delivery Devices Corporation Information
Table 78. Vectura Delivery Devices Description and Major Businesses
Table 79. Vectura Delivery Devices Product Models, Descriptions and Specifications
Table 80. Vectura Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vectura Delivery Devices Sales Value Proportion by Product in 2024
Table 82. Vectura Delivery Devices Sales Value Proportion by Application in 2024
Table 83. Vectura Delivery Devices Sales Value Proportion by Geographic Area in 2024
Table 84. Vectura Delivery Devices Dry Powder Inhalation Device SWOT Analysis
Table 85. Vectura Delivery Devices Recent Developments
Table 86. MannKind Corporation Corporation Information
Table 87. MannKind Corporation Description and Major Businesses
Table 88. MannKind Corporation Product Models, Descriptions and Specifications
Table 89. MannKind Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. MannKind Corporation Sales Value Proportion by Product in 2024
Table 91. MannKind Corporation Sales Value Proportion by Application in 2024
Table 92. MannKind Corporation Sales Value Proportion by Geographic Area in 2024
Table 93. MannKind Corporation Dry Powder Inhalation Device SWOT Analysis
Table 94. MannKind Corporation Recent Developments
Table 95. MicroDose Therapeutx Corporation Information
Table 96. MicroDose Therapeutx Description and Major Businesses
Table 97. MicroDose Therapeutx Product Models, Descriptions and Specifications
Table 98. MicroDose Therapeutx Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. MicroDose Therapeutx Recent Developments
Table 100. GSK Corporation Information
Table 101. GSK Description and Major Businesses
Table 102. GSK Product Models, Descriptions and Specifications
Table 103. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. GSK Recent Developments
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Major Businesses
Table 107. Novartis Product Models, Descriptions and Specifications
Table 108. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Novartis Recent Developments
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Product Models, Descriptions and Specifications
Table 113. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. AstraZeneca Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Product Models, Descriptions and Specifications
Table 118. Boehringer Ingelheim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Orion Pharma Corporation Information
Table 121. Orion Pharma Description and Major Businesses
Table 122. Orion Pharma Product Models, Descriptions and Specifications
Table 123. Orion Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Orion Pharma Recent Developments
Table 125. ​Liquidia Technologies​ Corporation Information
Table 126. ​Liquidia Technologies​ Description and Major Businesses
Table 127. ​Liquidia Technologies​ Product Models, Descriptions and Specifications
Table 128. ​Liquidia Technologies​ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. ​Liquidia Technologies​ Recent Developments
Table 130. ​Teva Pharmaceutical Industries​ Corporation Information
Table 131. ​Teva Pharmaceutical Industries​ Description and Major Businesses
Table 132. ​Teva Pharmaceutical Industries​ Product Models, Descriptions and Specifications
Table 133. ​Teva Pharmaceutical Industries​ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. ​Teva Pharmaceutical Industries​ Recent Developments
Table 135. Chiesi​​ Corporation Information
Table 136. Chiesi​​ Description and Major Businesses
Table 137. Chiesi​​ Product Models, Descriptions and Specifications
Table 138. Chiesi​​ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Chiesi​​ Recent Developments
Table 140. Hovione Corporation Information
Table 141. Hovione Description and Major Businesses
Table 142. Hovione Product Models, Descriptions and Specifications
Table 143. Hovione Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Hovione Recent Developments
Table 145. Nemera Corporation Information
Table 146. Nemera Description and Major Businesses
Table 147. Nemera Product Models, Descriptions and Specifications
Table 148. Nemera Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Nemera Recent Developments
Table 150. Dürr Corporation Information
Table 151. Dürr Description and Major Businesses
Table 152. Dürr Product Models, Descriptions and Specifications
Table 153. Dürr Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Dürr Recent Developments
Table 155. Shanghai Huarui Corporation Information
Table 156. Shanghai Huarui Description and Major Businesses
Table 157. Shanghai Huarui Product Models, Descriptions and Specifications
Table 158. Shanghai Huarui Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Shanghai Huarui Recent Developments
Table 160. Hangzhou Changxi Pharmaceutical Corporation Information
Table 161. Hangzhou Changxi Pharmaceutical Description and Major Businesses
Table 162. Hangzhou Changxi Pharmaceutical Product Models, Descriptions and Specifications
Table 163. Hangzhou Changxi Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Hangzhou Changxi Pharmaceutical Recent Developments
Table 165. Suzhou Inha Medicine Corporation Information
Table 166. Suzhou Inha Medicine Description and Major Businesses
Table 167. Suzhou Inha Medicine Product Models, Descriptions and Specifications
Table 168. Suzhou Inha Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Suzhou Inha Medicine Recent Developments
Table 170. Shenzhen Resproly Biopharmaceuticals Corporation Information
Table 171. Shenzhen Resproly Biopharmaceuticals Description and Major Businesses
Table 172. Shenzhen Resproly Biopharmaceuticals Product Models, Descriptions and Specifications
Table 173. Shenzhen Resproly Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Shenzhen Resproly Biopharmaceuticals Recent Developments
Table 175. Key Raw Materials Distribution
Table 176. Raw Materials Key Suppliers
Table 177. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 178. Milestones in Production Technology Evolution
Table 179. Distributors List
Table 180. Market Trends and Market Evolution
Table 181. Market Drivers and Opportunities
Table 182. Market Challenges, Risks, and Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources


List of Figures
Figure 1. Dry Powder Inhalation Device Product Picture
Figure 2. Global Dry Powder Inhalation Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Single Dose Product Picture
Figure 4. Multiple Doses Product Picture
Figure 5. Storage Type Product Picture
Figure 6. Global Dry Powder Inhalation Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Asthmatic
Figure 8. COPD
Figure 9. Other
Figure 10. Dry Powder Inhalation Device Report Years Considered
Figure 11. Global Dry Powder Inhalation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 13. Global Dry Powder Inhalation Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Dry Powder Inhalation Device Revenue Market Share by Region (2020-2031)
Figure 15. Global Dry Powder Inhalation Device Sales (2020-2031) & (K Units)
Figure 16. Global Dry Powder Inhalation Device Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Dry Powder Inhalation Device Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Dry Powder Inhalation Device Sales Volume Market Share in 2024
Figure 19. Global Dry Powder Inhalation Device Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Single Dose Revenue Market Share by Manufacturer in 2024
Figure 22. Multiple Doses Revenue Market Share by Manufacturer in 2024
Figure 23. Storage Type Revenue Market Share by Manufacturer in 2024
Figure 24. Global Dry Powder Inhalation Device Sales Market Share by Type (2020-2031)
Figure 25. Global Dry Powder Inhalation Device Revenue Market Share by Type (2020-2031)
Figure 26. Global Dry Powder Inhalation Device Sales Market Share by Application (2020-2031)
Figure 27. Global Dry Powder Inhalation Device Revenue Market Share by Application (2020-2031)
Figure 28. North America Dry Powder Inhalation Device Sales YoY (2020-2031) & (K Units)
Figure 29. North America Dry Powder Inhalation Device Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Dry Powder Inhalation Device Sales Revenue (US$ Million) in 2024
Figure 31. North America Dry Powder Inhalation Device Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Dry Powder Inhalation Device Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Dry Powder Inhalation Device Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Dry Powder Inhalation Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Dry Powder Inhalation Device Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Dry Powder Inhalation Device Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Dry Powder Inhalation Device Sales Revenue (US$ Million) in 2024
Figure 41. Europe Dry Powder Inhalation Device Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Dry Powder Inhalation Device Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Dry Powder Inhalation Device Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Dry Powder Inhalation Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 46. France Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Dry Powder Inhalation Device Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Dry Powder Inhalation Device Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Dry Powder Inhalation Device Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Dry Powder Inhalation Device Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Dry Powder Inhalation Device Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Dry Powder Inhalation Device Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Dry Powder Inhalation Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 61. India Dry Powder Inhalation Device Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Dry Powder Inhalation Device Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Dry Powder Inhalation Device Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Dry Powder Inhalation Device Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Dry Powder Inhalation Device Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Dry Powder Inhalation Device Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Dry Powder Inhalation Device Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Dry Powder Inhalation Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Dry Powder Inhalation Device Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Dry Powder Inhalation Device Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Dry Powder Inhalation Device Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Dry Powder Inhalation Device Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Dry Powder Inhalation Device Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Dry Powder Inhalation Device Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Dry Powder Inhalation Device Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Dry Powder Inhalation Device Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Dry Powder Inhalation Device Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Dry Powder Inhalation Device Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Dry Powder Inhalation Device Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Dry Powder Inhalation Device Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Dry Powder Inhalation Device Revenue (2020-2025) & (US$ Million)
Figure 82. Dry Powder Inhalation Device Industry Chain Mapping
Figure 83. Regional Dry Powder Inhalation Device Manufacturing Base Distribution (%)
Figure 84. Global Dry Powder Inhalation Device Production Market Share by Region (2020-2031)
Figure 85. Dry Powder Inhalation Device Production Process
Figure 86. Regional Dry Powder Inhalation Device Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit